Int J Pediatr Otorhinolaryngol:镰状细胞贫血症儿童感官听力损失研究

2019-01-13 AlexYang MedSci原创

据报道,感官听力损失(SNHL)在镰状细胞贫血症(SCD)群体中的发病率增加,很可能继发于耳毒性药物治疗方案和镰状细胞,最终导致器官的损伤。然而,该群体的SNHL的风险和保护性因素还没有很好的阐释。最近,有研究人员描述了SCD儿童中的听力情况以及SNHL在该群体中的患病率和后遗症情况。研究包括了2010年到2016年的2600名SCD儿童患者的综合临床数据。研究发现,共有181名SCD儿童(97名

据报道,感官听力损失(SNHL)在镰状细胞贫血症(SCD)群体中的发病率增加,很可能继发于耳毒性药物治疗方案和镰状细胞,最终导致器官的损伤。然而,该群体的SNHL的风险和保护性因素还没有很好的阐释。最近,有研究人员描述了SCD儿童中的听力情况以及SNHL在该群体中的患病率和后遗症情况。

研究包括了2010年到2016年的2600名SCD儿童患者的综合临床数据。研究发现,共有181名SCD儿童(97名男性,153名HbSS)经历了听力测试,共包括了276次听力测试,每名患者1到9次。第一次听力图的平均年龄为8.9±5.2。第一次听力图结果阐释了29.8%的患者具有先期脑梗塞,25.4%的患者具有先期异常的经颅多普勒检查结果。总的来说,13.3%的具有记录的听力损失,6.6%的具有SNHL。另外,那些具有SNHL的患者的平均纯音听觉阈值(PTA)范围从轻度到永久性听力损失(左边:43.3±28.9;右边:40.8±29.7),且重度听力损失的比例更高。

最后,研究人员指出,SCD儿童患者中的听力损失发病率显著,听力损失程度从正常到永久。尽管SNHL在SCD患者中的总患病率低,但是基线听力筛查还是需要的。

原始出处:

Farrell AN, Landry AM, Yee ME et al. Sensorineural hearing loss in children with sickle cell disease. Int J Pediatr Otorhinolaryngol. Dec 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1776811, encodeId=02dc1e76811c9, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Tue Jun 11 03:33:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638960, encodeId=5bc816389600e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Apr 04 23:33:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951475, encodeId=6b7419514e5cd, content=<a href='/topic/show?id=afc3532e51e' target=_blank style='color:#2F92EE;'>#感官听力损失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53275, encryptionId=afc3532e51e, topicName=感官听力损失)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Oct 25 19:33:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727843, encodeId=06e61e278430b, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 26 22:33:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306316, encodeId=08611306316b5, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481190, encodeId=6a0114811906d, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615500, encodeId=fefb161550025, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1776811, encodeId=02dc1e76811c9, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Tue Jun 11 03:33:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638960, encodeId=5bc816389600e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Apr 04 23:33:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951475, encodeId=6b7419514e5cd, content=<a href='/topic/show?id=afc3532e51e' target=_blank style='color:#2F92EE;'>#感官听力损失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53275, encryptionId=afc3532e51e, topicName=感官听力损失)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Oct 25 19:33:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727843, encodeId=06e61e278430b, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 26 22:33:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306316, encodeId=08611306316b5, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481190, encodeId=6a0114811906d, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615500, encodeId=fefb161550025, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1776811, encodeId=02dc1e76811c9, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Tue Jun 11 03:33:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638960, encodeId=5bc816389600e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Apr 04 23:33:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951475, encodeId=6b7419514e5cd, content=<a href='/topic/show?id=afc3532e51e' target=_blank style='color:#2F92EE;'>#感官听力损失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53275, encryptionId=afc3532e51e, topicName=感官听力损失)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Oct 25 19:33:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727843, encodeId=06e61e278430b, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 26 22:33:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306316, encodeId=08611306316b5, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481190, encodeId=6a0114811906d, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615500, encodeId=fefb161550025, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1776811, encodeId=02dc1e76811c9, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Tue Jun 11 03:33:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638960, encodeId=5bc816389600e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Apr 04 23:33:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951475, encodeId=6b7419514e5cd, content=<a href='/topic/show?id=afc3532e51e' target=_blank style='color:#2F92EE;'>#感官听力损失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53275, encryptionId=afc3532e51e, topicName=感官听力损失)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Oct 25 19:33:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727843, encodeId=06e61e278430b, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 26 22:33:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306316, encodeId=08611306316b5, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481190, encodeId=6a0114811906d, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615500, encodeId=fefb161550025, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
    2019-03-26 feather89
  5. [GetPortalCommentsPageByObjectIdResponse(id=1776811, encodeId=02dc1e76811c9, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Tue Jun 11 03:33:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638960, encodeId=5bc816389600e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Apr 04 23:33:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951475, encodeId=6b7419514e5cd, content=<a href='/topic/show?id=afc3532e51e' target=_blank style='color:#2F92EE;'>#感官听力损失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53275, encryptionId=afc3532e51e, topicName=感官听力损失)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Oct 25 19:33:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727843, encodeId=06e61e278430b, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 26 22:33:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306316, encodeId=08611306316b5, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481190, encodeId=6a0114811906d, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615500, encodeId=fefb161550025, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
    2019-01-15 ysjykql
  6. [GetPortalCommentsPageByObjectIdResponse(id=1776811, encodeId=02dc1e76811c9, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Tue Jun 11 03:33:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638960, encodeId=5bc816389600e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Apr 04 23:33:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951475, encodeId=6b7419514e5cd, content=<a href='/topic/show?id=afc3532e51e' target=_blank style='color:#2F92EE;'>#感官听力损失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53275, encryptionId=afc3532e51e, topicName=感官听力损失)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Oct 25 19:33:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727843, encodeId=06e61e278430b, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 26 22:33:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306316, encodeId=08611306316b5, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481190, encodeId=6a0114811906d, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615500, encodeId=fefb161550025, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1776811, encodeId=02dc1e76811c9, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Tue Jun 11 03:33:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638960, encodeId=5bc816389600e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Apr 04 23:33:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951475, encodeId=6b7419514e5cd, content=<a href='/topic/show?id=afc3532e51e' target=_blank style='color:#2F92EE;'>#感官听力损失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53275, encryptionId=afc3532e51e, topicName=感官听力损失)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Oct 25 19:33:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727843, encodeId=06e61e278430b, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 26 22:33:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306316, encodeId=08611306316b5, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481190, encodeId=6a0114811906d, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615500, encodeId=fefb161550025, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Tue Jan 15 05:33:00 CST 2019, time=2019-01-15, status=1, ipAttribution=)]

相关资讯

Hum Mol Genet:FOXF2对人类和小鼠耳蜗的发育是需要的

控制人类耳蜗发育的分子机制仍旧大部分未知。最近,有研究人员通过基因组测序在一名患有永久性感官听力损失的儿童中鉴定了一个纯合的变异c.325A > T (p.I109F),并且该儿童具有不完全的分割I型耳蜗异常。研究发现,该变异位点在公共数据库中并未发现,并且在种族匹配的1000个对照个体中也没有发现。I109在FOXF2蛋白的Fox结构域中是一个高度保守的氨基酸残基,FOXF2是Fox转录因

Laryngoscope:中耳超声微泡地塞米松治疗能够减轻噪音诱导的听力损失

最近,有研究人员测试了超声(US)协助微泡(MBs)给药反圆窗膜地塞米松(DEX)治疗的效果,并在动物模型中评估了噪音接触的预防作用。研究包括了42只豚鼠并分成3个小组:鼓膜泡填充DEX和MBs并暴露于US组,即 US-MBs (USM) 组;卵圆窗浸泡(RWS)组,且没有US接触;以及一个对照组。上述操作均在白噪音接触前的2个小时进行。研究人员评估了耳蜗损伤,包括了听觉阈值变化、听毛损失和耳蜗H

Genet Test Mol Biomarkers:中国河南省非综合症听力损失儿童中GJB2、SLC26A4、MT-RNA1、和GJB3变异分析

听力损伤是最常见的感觉神经障碍之一,困扰着人类的正常活动。其中大约一半的案例具有遗传上的病因。能够引起耳聋的遗传变异的分布和频率在不同的种族和地理区域中具有显著的差异。最近,有研究人员对130名散发性非综合征性听力损失(NSHL)儿童进行了基于芯片的突变检测。研究人员在4个最常见的耳聋相关基因(GJB2、SLC26A4、MT-RNA1、和GJB3)的9个病理变异进行了检测。研究发现,分析群体中有5

盘点:听力损失疾病治疗盘点

【1】Health Technol Assess:中耳炎伴随积液听力损失儿童的口服类固醇治疗 中耳炎伴随积液(OME)听力损失儿童一般是通过外科手术干预、听力助听器或者等待观察进行治疗。一种安全的、廉价的和有效的治疗方法能够增加治疗选择。小规模的简单试验发现口服类固醇能够产生短期的治疗效果。最近,有研究人员在患有永久OME症状和双边OME以及听力损失儿童中,确定了为期7天口服类固醇在

盘点:听力损失研究盘点

听力损失(hearing loss)又称聋度(deafness)或听力级(hearing level)。是人耳在某一频率的听阈比正常听阈高出的分贝数。由于年龄关系产生的听力损失称为老年性耳聋;由于社会环境噪声(年龄、职业性噪声和疾病等影响除外)产生的听力损失称为社会性耳聋;职业性噪声导致的听力损失称为噪声性耳聋。梅斯医学小编整理了近期听力损失的研究进展,与大家一起分享学习!【1】Diabeto

盘点:听力损失机制研究

【1】J Am Acad Audiol:听力损失严重度与主管耳鸣响度关系研究听力损失经常与耳鸣的幻听相关。然而,听力损失的严重度与耳鸣响度(考虑到其他的变量,比如情绪障碍)之间的相关性仍旧没有很好的阐释。这对听力学家,尤其是耳鸣康复方面专家来讲是非常重要的,因为患者总是询问是否耳鸣响度的增加会使得他们的听力变得更差。最近,有研究人员探索了耳鸣响度与纯音听力阈值之间的关系。研究包括了445名连续